Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SSII | SIBN |
|---|---|---|
| Price | $2.74 | $19.10 |
| Change today | ▼ 0.72% | ▼ 2.30% |
| Market cap | $548.00M | $856.03M |
| Return, 3 months | -27.5% | +9.6% |
| Return, year to date | -51.8% | -3.1% |
| Return, 1 year | -59.3% | +25.6% |
| P/E (TTM) | -45.7 | -57.9 |
| P/B | 10.3 | 4.7 |
| P/E percentile vs own 5y | 67th | 1st |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +39.4% | +15.2% |
| Net profit growth (YoY) | -936.8% | +33.6% |
| Gross margin | 47.6% | 79.5% |
| Operating margin | -16.2% | -8.3% |
| Net margin | -23.7% | -6.9% |
| Return on equity | -26.1% | -8.3% |
| Analyst target vs. price | – | +28.3% |
| Analyst buy share | – | 100% |
| RSI (14) | 30 | 54 |
| 30-day volatility | 43.2% | 35.1% |
| Max drawdown, 1 year | -73.2% | -45.7% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
